| Active ingredient (INN) | Cleviprex |
|---|---|
| ATC level 5 | C08CA16 |
| ATC level 4 | C08CA |
| Therapeutic category | Auto-created by Agencia Española de Medicamentos — Problemas de Suministro scraper |
| Controlled substance |
| No |
| Marketing-authorisation holders | Chiesi USA, Inc., CHIESI FARMACEUTICI S.P.A. |
|---|
| Registrations on file | 4 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| CLEVIPREX clevidipine | 25 mg | — | 🇦🇺 AU | — | Active |
| CLEVIPREX clevidipine | 50 mg | — | 🇦🇺 AU | — | Active |
| Cleviprex | .5mg/mL | emulsion | 🇺🇸 US | Chiesi USA, Inc. | Active |
| CLEVIPREX | — | emulsion | 🇨🇦 CA | CHIESI FARMACEUTICI S.P.A. | Active |